Skip to main content

Advertisement

Log in

Factors influencing the outcome of idiopathic sudden sensorineural hearing loss treated with hyperbaric oxygen therapy

  • Otology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Idiopathic sudden sensorineural hearing loss (ISSNHL) is an otologic emergency with an incidence of about 5–20 per 100,000 of the population per year. There is no universally accepted standard protocol for the treatment of patients with ISSNHL. Hyperbaric oxygen therapy (HBOT), was first reported to improve the outcome following acute inner ear disorders during the late 1960s by both French and German authors. The increase in perilymph oxygenation produced by HBOT provides logical basis for the use of this treatment modality in ISSNHL. We reviewed the records of 97 cases that received HBOT for SSNHL to identify the factors that may affect the treatment outcomes. The effects of age, gender, affected ear, status of the contralateral ear, symptoms associated with hearing loss, presence of a cardiovascular disease, dyslipidemia, history of diabetes mellitus, seasonal factor, smoking, degree of hearing loss, audiogram type, medical treatments provided prior to HBOT, onset time, and number of HBOT sessions were evaluated. The mean hearing gain in all cases after the HBOT was 29.5 dB. The gains were statistically significant in the following cases: early onset of HBOT (p = 0.016), higher number of HBOT sessions (p < 0.01), steroid usage (p = 0.009), low frequency-ascending and total audiogram configuration (p < 0.01) and profound hearing loss (p = 0.011). The success rate was significantly lower in cases with high frequency-descending audiogram configuration (p < 0.001). The most important factor affected the prognosis favorably was found as steroid therapy. This retrospective study and our clinical experience suggest that HBOT has beneficial effects when administered in the early phase of the disease together with steroids. HBOT is a safe practice when used properly by an experienced hyperbaric team. In the treatment of ISSNHL, 20 sessions of HBOT at 2.5 ATA can be tolerated well besides some minor side effects. HBOT should be considered for the cases especially with total or profound hearing loss.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Byl FM (1984) Sudden hearing loss: eight years’ experience and suggested prognostic table. Laryngoscope 94:647–662

    Article  PubMed  Google Scholar 

  2. Wilson WR, Byl FM, Laird N (1980) The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A doubleblind clinical study. Arch Otolaryngol 106:772–776

    CAS  PubMed  Google Scholar 

  3. Mattox DE, Simmons FB (1977) Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 86:463–480

    CAS  PubMed  Google Scholar 

  4. Simmons FB (1973) Sudden idiopathic sensori-neural hearing loss: some observations. Laryngoscope 83:1221–1227

    Article  CAS  PubMed  Google Scholar 

  5. Van Dishoeck H, Bierman T (1957) Sudden perceptive deafness and viral infection (report of the first one hundred patients). Ann Otol Rhinol Laryngol 66:963–980

    Google Scholar 

  6. Rasmussen H (1949) Sudden deafness. Acta Otolaryngol 37:65–70

    Article  Google Scholar 

  7. Simmons FB (1968) Theory of membrane breaks in sudden hearing loss. Arch Otolarngol 88:41–48

    CAS  Google Scholar 

  8. Stokroos RJ, Albers FWJ (1996) The etiology of idiopathic sudden sensorineural hearing loss: a review of the literature. Acta Otorhinolaryngol Belg 50:69–76

    CAS  PubMed  Google Scholar 

  9. Agarwal L, Pothier DD (2009) Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 4:CD003422. doi:10.1002/14651858.CD003422.pub4

  10. Lamm H (1968) Klinische Ergebnisse nach Behandlung von Innenohrschwerhörigkeiten mit hyperbaren Sauerstoff. Diskuss. Beitrag HNO-Jahreskongress der DDR, Halle

    Google Scholar 

  11. Appaix A, Demard F (1970) Hyperbaric oxygenotherapy and sudden perceptive deafness. Rev Laryngol Otol Rhinol (Bord) 91:951–972

    CAS  Google Scholar 

  12. Aslan I, Oysu C, Veyseller B, Baserer N (2002) Does the addition of hyperbaric oxygen therapy to the conventional treatment modalities influence the outcome of sudden deafness? Otolaryngol Head Neck Surg 126:121–126

    Article  PubMed  Google Scholar 

  13. Topuz E, Yigit O, Cinar O, Seven H (2004) Should hyperbaric oxygen be added to treatment in idiopathic sudden sensorineural hearing loss? Eur Arch Otorhinolaryngol 261:393–396

    Article  PubMed  Google Scholar 

  14. Narozny W, Kuczkowski J, Kot J, Stankiewicz C, Sicko Z, Mikaszewski B (2006) Prognostic factors in sudden sensorineural hearing loss: our experience and a review of the literature. Ann Otol Rhinol Laryngol 115(7):553–558

    PubMed  Google Scholar 

  15. Horn CE, Himel HN, Selesnick SH (2005) Hyperbaric oxygen therapy for sudden sensorineural hearing loss: a prospective trial of patients failing steroid and antiviral treatment. Otol Neurotol 26(5):882–889

    Article  PubMed  Google Scholar 

  16. Samim E, Kilic R, Özdek A, Gocmen H, Eryilmaz A, Unlu I (2004) Combined treatment of sudden sensorineural hearing loss with steroid, dextran and piracetam: experience with 68 cases. Eur Arch Otorhinolaryngol 261:187–190

    Article  PubMed  Google Scholar 

  17. Feldmeier JJ (ed) (2003) Hyperbaric oxygen: indications and results; the hyperbaric oxygen therapy committee report. Undersea and Hyperbaric Medical Society, Kensington

    Google Scholar 

  18. Lamm K, Arnold W (1999) Successful treatment of noise-induced cochlear ischemia, hypoxia, and hearing loss. Ann N Y Acad Sci 884:233–248

    Article  CAS  PubMed  Google Scholar 

  19. Lamm K, Lamm C, Arnold W (1998) Effect of isobaric oxygen versus hyperbaric oxygen on the normal and noise-damaged hypoxic and ischemic guinea pig inner ear. Adv Otorhinolaryngol 54:59–85

    CAS  PubMed  Google Scholar 

  20. Mazzoli M, Van Camp G, Newton V, Giarbini N, Declau F, Parving A (2003) Recommendations for the description of genetic and audiological data for families with nonsyndromic hereditary hearing impairment. Audiol Med 1:148–150

    Article  Google Scholar 

  21. Goodman AC (1965) Reference zero levels for pure-tone audiometers. Asha 7:262–263

    Google Scholar 

  22. Ballesteros F, Alobid I, Tassies D, Reverter JC, Scharf RE, Guilemany JM, Bernal-Sprekelsen M (2009) Is there an overlap between sudden neurosensorial hearing loss and cardiovascular risk factors? Audiol Neurotol 14:139–145

    Article  CAS  Google Scholar 

  23. Lamm K, Lamm H, Arnold W (1998) Effect of hyperbaric oxygen therapy in comparison to conventional or placebo therapy or no treatment in idiopathic sudden hearing loss, acoustic trauma, noise induced hearing and tinnitus. A literature survey. Adv Otorhinolaryngol 54:86–99

    CAS  PubMed  Google Scholar 

  24. Nakashima T, Fukata S, Yanagita N (1998) Hyperbaric oxygen therapy for sudden deafness. Adv Otorhinolaryngol 54:100–109

    CAS  PubMed  Google Scholar 

  25. Bennett MH, Kertesz T, Yeung P (2007) Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database Syst Rev 1:CD004739. doi:10.1002/14651858.CD004739.pub3

  26. Desloovere C, Germoupre P (1997) Sudden sensorineural deafness: treatment with hyperbaric oxygen therapy after failure of ten day course of “classical” drug therapy. In: Proceedings of the 23rd EUBS Congress. European Underwater and Baromedical Society, Bled, pp198–202

  27. Welslau W, Almeling M, Lommerging A, Busch R, Trombitas G, Hesse G (1997) How many HBO treatments are necessary for the therapy of sudden deafness and acute tinnitus? In: Proceedings of the 23rd EUBS Congress. European Underwater and Baromedical Society, Bled, pp 203–209

  28. Plafki C, Peters P, Almeling M, Welslau W, Busch R (2000) Complications and side effects of hyperbaric oxygen therapy. Aviat Space Environ Med 71:119–124

    CAS  PubMed  Google Scholar 

  29. Fernau JL, Hirsch BE, Derkay C, Ramasastry S, Schaefer SE (1992) Hyperbaric oxygen therapy: effect on middle ear and eustachian tube function. Laryngoscope 102:48–52

    Article  CAS  PubMed  Google Scholar 

  30. Vahidova D, Sen P, Papesch M, Zein-Sanchez MP, Mueller PH (2006) Does the slow compression technique of hyperbaric oxygen therapy decrease the incidence of middle-ear barotrauma? J Laryngol Otol 120(6):446–449

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest statement

The authors declare that they have no conflict of interest with any financial support or any commercial source that may, directly or indirectly, interfere with the results reported in the present article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Şefika Körpinar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Körpinar, Ş., Alkan, Z., Yiğit, Ö. et al. Factors influencing the outcome of idiopathic sudden sensorineural hearing loss treated with hyperbaric oxygen therapy. Eur Arch Otorhinolaryngol 268, 41–47 (2011). https://doi.org/10.1007/s00405-010-1336-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-010-1336-6

Keywords

Navigation